SCHEMBL691132

SCHEMBL691132

CCOc1ccc(C=CC(=O)O)cc1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.69
RAB9A P51151 3/20 0.69
KDM4E B2RXH2 2/20 0.69
ALDH1A1 P00352 2/20 0.69
MAPT P10636 2/20 0.69
HTT P42858 1/20 0.69
KMT2A Q03164 1/20 0.69
POLB P06746 1/20 0.68
SMN1; SMN2 Q16637 2/20 0.67
THRB P10828 1/20 0.66
ATM Q13315 1/20 0.66
MAOB P27338 8/20 0.65
MAOA P21397 1/20 0.65
ABCG2 Q9UNQ0 1/20 0.63
RELA Q04206 1/20 0.62
TP53 P04637 1/20 0.61
EGFR P00533 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL691131 1.00 NPC1 (0.69) NPC1RAB9AKDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL8023969 0.98 NPC1 (0.68) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL27766810 0.88 NPC1 (0.60) NPC1RAB9AKDM4EALDH1A1MAPT
Diethanolamine SCHEMBL5054343 0.88 KDM4E (0.57) NPC1RAB9AKDM4EALDH1A1MAPT
Diethanolamine SCHEMBL5054345 0.88 KDM4E (0.57) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL9556747 0.87 NPC1 (0.56) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL7969488 0.87 KDM4E (0.73) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL7969484 0.87 KDM4E (0.73) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL417823 0.86 ABCG2 (0.65) NPC1RAB9AKDM4EALDH1A1MAPT
SCHEMBL154581 0.86 ABCG2 (0.65) KMT2APOLBTHRBATMABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12350251-B2 Sexual health enhancement composition REV PHARMACEUTICALS, INC. (US) 2025-07-08 US claimed
CN-117380269-B Oil-soluble organic molybdenum catalyst and preparation method and application thereof 北京高新利华科技股份有限公司 2024-04-05 CN claimed
CN-117380269-A Oil-soluble organic molybdenum catalyst and preparation method and application thereof 北京高新利华科技股份有限公司 2024-01-12 CN claimed
US-20230383163-A1 COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE KD FINECHEM CO., LTD. (KR) 2023-11-30 US claimed
EP-4239033-A1 COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE KD Finechem Co., Ltd. (KR) 2023-09-06 EP claimed
CN-116472324-A Cooling liquid composition for electric automobile KD精细化工有限公司 2023-07-21 CN claimed
WO-2023134886-A1 SKIN MICROBIOME FRIENDLY SUNSCREENS BASF SE (DE) 2023-07-20 WO claimed
WO-2022092490-A1 COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE 주식회사 케이디파인켐 2022-05-05 WO claimed
WO-2020053580-A1 MOLECULAR HEATER FOR PLANTS THE UNIVERSITY OF BRISTOL (GB) 2020-03-19 WO claimed
US-20190343791-A1 SEXUAL HEALTH ENHANCEMENT COMPOSITION REV PHARMACEUTICALS, INC. 2019-11-14 US claimed
WO-2018094377-A1 SEXUAL HEALTH ENHANCEMENT COMPOSITION REV Pharmaceuticals LLC (US) 2018-05-24 WO claimed
EP-2328938-B1 RADICALLY FUNCTIONALIZED OLEFIN-BASED POLYMER WITH REDUCED MOLECULAR WEIGHT CHANGE AND METHOD DOW GLOBAL TECHNOLOGIES LLC (US) 2015-04-01 EP claimed
EP-1181000-B1 A METHOD FOR OBTAINING PHOTOSTABLE SUNSCREEN COMPOSITIONS SOL GEL TECHNOLOGIES LTD (IL) 2007-02-07 EP claimed
US-5961875-A Antifreeze/coolant composition containing cinnamic acid CCI CO., LTD. (JP) 1999-10-05 US claimed
EP-0185066-B1 SULPHUR-CONTAINING DERIVATIVES OF PARA-METHOXYCINNAMIC ACID, PRODUCTION PROCESSES THEREOF, DERMO-PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND APPLICATIONS UNIVERSITE LOUIS PASTEUR (STRASBOURG I) (FR) 1988-04-20 EP claimed
US-20260001999-A1 HYDROPHILIC OIL REPELLENT POLYMER SUMITOMO CHEMICAL CO (JP) 2026-01-01 US disclosed
US-12350251-B2 Sexual health enhancement composition REV PHARMACEUTICALS, INC. (US) 2025-07-08 US disclosed
US-3975429-A Cyclopropanemethyl esters of cinnamic acid and derivatives thereof ZOECON CORPORATION (US) 1976-08-17 US disclosed
US-3962219-A DISTYRYL-BENZOBISOXAZOLES BAYER AKTIENGESELLSCHAFT (DT) 1976-06-08 US disclosed
US-3940422-A ANTIALLERGEN KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (JA) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001999-A1 HYDROPHILIC OIL REPELLENT POLYMER CCR1, H1-3, CCR3 NPC1 265/4885RAB9A 3950/4885KDM4E 3780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.